{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:11:31Z","timestamp":1789755091765,"version":"4.0.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.tcm.2019.03.007","type":"journal-article","created":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T02:11:09Z","timestamp":1554171069000},"page":"104-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"title":["Acute heart failure"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2443-2927","authenticated-orcid":false,"given":"Lauren","family":"Sinnenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Givertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"27","key":"10.1016\/j.tcm.2019.03.007_bib0001","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.tcm.2019.03.007_bib0002","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.amjcard.2007.11.061","article-title":"Heart failure incidence and survival (from the atherosclerosis risk in communities study)","volume":"101","author":"Loehr","year":"2008","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.tcm.2019.03.007_sbref0003","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","article-title":"Heart disease and stroke statistics\u20142018 update: A report from the American Heart Association","volume":"137","author":"Benjamin","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2019.03.007_bib0004","unstructured":"Donkor A, McDonagh T, Hardman S, National Heart Failure Audit April 2015\u2013March 2016 [Internet]. 2016. Available from: https:\/\/www.ucl.ac.uk\/nicor\/audits\/heartfailure\/documents\/annualreports\/annual-report-2015-6-v8.pdf."},{"issue":"2","key":"10.1016\/j.tcm.2019.03.007_bib0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","article-title":"Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"149","author":"Adams","year":"2005","journal-title":"Am Heart J"},{"issue":"5","key":"10.1016\/j.tcm.2019.03.007_bib0006","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1161\/CIRCOUTCOMES.109.883256","article-title":"Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission","volume":"2","author":"Krumholz","year":"2009","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"24","key":"10.1016\/j.tcm.2019.03.007_bib0007","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1001\/jama.2016.18533","article-title":"Association between hospital penalty status under the hospital readmission reduction program and readmission rates for target and nontarget conditions","volume":"316","author":"Desai","year":"2016","journal-title":"JAMA"},{"issue":"24","key":"10.1016\/j.tcm.2019.03.007_bib0008","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1001\/jama.2018.19232","article-title":"Association of the Hospital Readmissions Reduction Program with mortality among Medicare beneficiaries hospitalized for heart failure, acute myocardial infarction, and pneumonia","volume":"320","author":"Wadhera","year":"2018","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.tcm.2019.03.007_bib0009","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jacc.2008.04.028","article-title":"Predictors of in-hospital mortality in patients hospitalized for heart failure","volume":"52","author":"Abraham","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"10.1016\/j.tcm.2019.03.007_bib0010","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.jacc.2014.05.071","article-title":"Effect of serelaxin on mode of death in acute heart failure","volume":"64","author":"Felker","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.tcm.2019.03.007_bib0011","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1056\/NEJMoa1601895","article-title":"Effect of ularitide on cardiovascular mortality in acute heart failure","volume":"376","author":"Packer","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.tcm.2019.03.007_bib0012","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1100171","article-title":"Effect of nesiritide in patients with acute decompensated heart failure","volume":"365","author":"O'Connor","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.tcm.2019.03.007_bib0013","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/HHF.0b013e318291329a","article-title":"Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association","volume":"6","author":"Heidenreich","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.tcm.2019.03.007_bib0014","series-title":"Cardiovascular Therapeutics: a Companion to Braunwald's Heart Disease","first-page":"281","article-title":"Strategies for management of acute decompensated heart failure","author":"Givertz","year":"2013"},{"issue":"10","key":"10.1016\/j.tcm.2019.03.007_bib0015","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jacc.2018.06.050","article-title":"Identifying pathophysiological mechanisms in heart failure with reduced versus preserved ejection fraction","volume":"72","author":"Tromp","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.tcm.2019.03.007_bib0016","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jchf.2017.04.007","article-title":"Biomarker profiles of acute heart failure patients with a mid-range ejection fraction","volume":"5","author":"Tromp","year":"2017","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10.1016\/j.tcm.2019.03.007_bib0017","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jchf.2013.07.009","article-title":"Characterization of a novel symptom of advanced heart failure: bendopnea","volume":"2","author":"Thibodeau","year":"2014","journal-title":"JACC Heart Fail"},{"issue":"9","key":"10.1016\/j.tcm.2019.03.007_bib0018","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.amjcard.2018.07.023","article-title":"Relation of volume overload to clinical outcomes in acute heart failure (From ASCEND-HF)","volume":"122","author":"Fudim","year":"2018","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.tcm.2019.03.007_bib0019","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.000806","article-title":"B-type natriuretic peptide predicts 30-day readmission for heart failure but not readmission for other causes","volume":"3","author":"Flint","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"22","key":"10.1016\/j.tcm.2019.03.007_sbref0019","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000490","article-title":"Role of biomarkers for the prevention, assessment, and management of heart failure: a scientific statement from the American Heart Association","volume":"135","author":"Chow","year":"2017","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.tcm.2019.03.007_bib0021","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jacc.2016.10.038","article-title":"Proenkephalin, renal dysfunction, and prognosis in patients with acute heart failure: a GREAT network study","volume":"69","author":"Ng","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.tcm.2019.03.007_bib0022","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/ejhf.749","article-title":"A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial","volume":"19","author":"Demissei","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.tcm.2019.03.007_bib0023","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1378\/chest.14-2608","article-title":"Lung ultrasound-implemented diagnosis of acute decompensated heart failure in the ED: a SIMEU multicenter study","volume":"148","author":"Pivetta","year":"2015","journal-title":"Chest"},{"issue":"15","key":"10.1016\/j.tcm.2019.03.007_bib0024","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008184","article-title":"Bedside ultrasound assessment of jugular venous compliance as a potential point\u2010of\u2010care method to predict acute decompensated heart failure 30\u2010day readmission","volume":"7","author":"Simon","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"17","key":"10.1016\/j.tcm.2019.03.007_bib0025","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1001\/archinternmed.2009.267","article-title":"Hospital at home for elderly patients with acute decompensation of chronic heart failure","volume":"169","author":"Tibaldi","year":"2009","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.tcm.2019.03.007_bib0026","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ahj.2012.07.033","article-title":"Risk stratification in acute heart failure: rationale and design of the STRATIFY and DECIDE studies","volume":"164","author":"Collins","year":"2012","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.tcm.2019.03.007_bib0027","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003581","article-title":"Design and rationale of a randomized trial of a care transition strategy in patients with acute heart failure discharged from the emergency department: GUIDED-HF (Get With the Guidelines in Emergency Department Patients with Heart Failure)","volume":"10","author":"Fermann","year":"2017","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.tcm.2019.03.007_bib0028","unstructured":"Pang P., Cole M. Short stay unit vs hospitalization in acute heart failure \u2013 full text view \u2013 ClinicalTrials.gov. Available from https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03302910."},{"issue":"25","key":"10.1016\/j.tcm.2019.03.007_bib0029","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1016\/j.jacc.2017.04.042","article-title":"Time-to-furosemide treatment and mortality in patients hospitalized with acute heart failure","volume":"69","author":"Matsue","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.tcm.2019.03.007_bib0030","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.tcm.2019.03.007_bib0031","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jchf.2017.10.001","article-title":"Efficacy of intravenous furosemide versus a novel, pH-neutral furosemide formulation administered subcutaneously in outpatients with worsening heart failure","volume":"6","author":"Gilotra","year":"2018","journal-title":"JACC Heart Fail"},{"issue":"2","key":"10.1016\/j.tcm.2019.03.007_bib0032","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/1755-5922.12109","article-title":"Comparison of metolazone versus chlorothiazide in acute decompensated heart failure with diuretic resistance","volume":"33","author":"Moranville","year":"2015","journal-title":"Cardiovasc Ther"},{"issue":"10","key":"10.1016\/j.tcm.2019.03.007_bib0033","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jchf.2018.04.008","article-title":"Randomized evaluation of heart failure with preserved ejection fraction patients with acute heart failure and dopamine","volume":"6","author":"Sharma","year":"2018","journal-title":"JACC Heart Fail"},{"issue":"11","key":"10.1016\/j.tcm.2019.03.007_bib0034","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.jacc.2016.09.004","article-title":"Efficacy and safety of tolvaptan in patients hospitalized with acute heart failure","volume":"69","author":"Felker","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.tcm.2019.03.007_bib0035","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/jamacardio.2017.2198","article-title":"Efficacy and safety of spironolactone in acute heart failure","volume":"2","author":"Butler","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"2","key":"10.1016\/j.tcm.2019.03.007_bib0036","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jchf.2015.08.005","article-title":"Aquapheresis versus intravenous diuretics and hospitalizations for heart failure","volume":"4","author":"Costanzo","year":"2016","journal-title":"JACC Heart Fail"},{"issue":"12","key":"10.1016\/j.tcm.2019.03.007_bib0037","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1001\/jamainternmed.2013.552","article-title":"Aggressive fluid and sodium restriction in acute decompensated heart failure","volume":"173","author":"Aliti","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"16","key":"10.1016\/j.tcm.2019.03.007_bib0038","first-page":"e240","article-title":"2013 ACCF\/AHA guideline for the management of heart failure","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"issue":"9860","key":"10.1016\/j.tcm.2019.03.007_bib0039","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(12)61855-8","article-title":"Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial","volume":"381","author":"Teerlink","year":"2013","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.tcm.2019.03.007_bib0040","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1001\/jama.297.17.1883","article-title":"Levosimendan vs dobutamine for patients with acute decompensated heart failure","volume":"297","author":"Mebazaa","year":"2007","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.tcm.2019.03.007_bib0041","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jacc.2016.01.031","article-title":"Acute treatment with omecamtiv mecarbil to increase contractility in acute heart failure","volume":"67","author":"Teerlink","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.tcm.2019.03.007_bib0042","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMoa1812851","article-title":"Angiotensin\u2013neprilysin inhibition in acute decompensated heart failure","volume":"380","author":"Velazquez","year":"2019","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.tcm.2019.03.007_bib0043","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","article-title":"Intraaortic balloon support for myocardial infarction with cardiogenic shock","volume":"367","author":"Thiele","year":"2012","journal-title":"N Engl J Med"},{"issue":"47","key":"10.1016\/j.tcm.2019.03.007_bib0044","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1093\/eurheartj\/ehx363","article-title":"Percutaneous short-term active mechanical support devices in cardiogenic shock: a systematic review and collaborative meta-analysis of randomized trials","volume":"38","author":"Thiele","year":"2017","journal-title":"Eur Heart J"},{"issue":"14","key":"10.1016\/j.tcm.2019.03.007_bib0045","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jacc.2014.07.958","article-title":"National trends in the utilization of short-term mechanical circulatory support: incidence, outcomes, and cost analysis","volume":"64","author":"Stretch","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.tcm.2019.03.007_bib0046","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.healun.2017.09.020","article-title":"Use of a percutaneous temporary circulatory support device as a bridge to decision during acute decompensation of advanced heart failure","volume":"37","author":"Hall","year":"2018","journal-title":"J Heart Lung Transplant"},{"issue":"7","key":"10.1016\/j.tcm.2019.03.007_bib0047","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/hrt.2009.175257","article-title":"Potentially detrimental cardiovascular effects of oxygen in patients with chronic left ventricular systolic dysfunction","volume":"96","author":"Park","year":"2010","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.tcm.2019.03.007_bib0048","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1001\/jama.2016.10260","article-title":"Effects of liraglutide on clinical stability among patients with advanced heart failure and reduced ejection fraction","volume":"316","author":"Margulies","year":"2016","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.tcm.2019.03.007_bib0049","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.117.028268","article-title":"Empagliflozin and clinical outcomes in patients with type 2 diabetes mellitus, established cardiovascular disease, and chronic kidney disease","volume":"137","author":"Wanner","year":"2018","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.tcm.2019.03.007_bib0050","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.tcm.2019.03.007_bib0051","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1056\/NEJMoa1808848","article-title":"Rivaroxaban in patients with heart failure, sinus rhythm, and coronary disease","volume":"379","author":"Zannad","year":"2018","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.tcm.2019.03.007_bib0052","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.cardfail.2015.04.004","article-title":"Health literacy predicts morbidity and mortality in rural patients with heart failure","volume":"21","author":"Moser","year":"2015","journal-title":"J Card Fail"},{"key":"10.1016\/j.tcm.2019.03.007_bib0053","unstructured":"Virtual visits in heart failure care transitions - Full Text View - ClinicalTrials.gov. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03675828."},{"key":"10.1016\/j.tcm.2019.03.007_bib0054","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ahj.2016.12.012","article-title":"Rehabilitation therapy in older acute heart failure patients (REHAB-HF) trial: design and rationale","volume":"185","author":"Reeves","year":"2017","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.tcm.2019.03.007_bib0055","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1161\/CIRCHEARTFAILURE.115.002153","article-title":"Discharge hospice referral and lower 30-day all-cause readmission in medicare beneficiaries hospitalized for heart failure","volume":"8","author":"Kheirbek","year":"2015","journal-title":"Circ Hear Fail"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173819300441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173819300441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T04:59:15Z","timestamp":1760936355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173819300441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1050173819300441"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2019.03.007","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute heart failure","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2019.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}